MA BM BCh PhD FRCP FHFA

Dr. Alexander Lyon is a Senior Lecturer in Cardiology at Imperial College London and a Consultant Cardiologist at the Royal Brompton Hospital. His clinical interests are in the field of heart failure, cardio-oncology, Takotsubo syndrome and the effects of major stresses of the heart, and gene therapy for chronic heart failure.

Alex has been the clinical lead for the Cardio-Oncology service at the Royal Brompton Hospital since 2011, specialising in surveillance and cardioprotection from modern cancer drugs, risk stratification and treatment of all cardiac complications of cancer treatment. The service was recently awarded a Gold Cardio-Oncology Centre of Excellence award from the International cardio-Oncology Society.

Alex is a co-chair of the first ESC Cardio-Oncology Guideline which was presented and published in August 2022 and a co-author of the 2021 BSE-BCOS echocardiography in cancer patient guideline.

Alex is the chair of the European Society of Cardiology (ESC) Council of Cardio-Oncology (2022-2024), the past president of the British Cardio-Oncology Society, a board member of International Cardio-Oncology Society (ICOS), and he is the cardiology advisor to the charity Macmillan Cancer. Alex is a co-investigator of the first Leducq Cardio-Oncology Transatlantic Research Network funded from 2020-2025 ($6M).

Alex has published over 180 scientific papers in peer-reviewed journals and Alex is a deputy editor of the European Heart Journal. His H-index is 57.